Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F; GISSI-Prevenzione Investigators. Marchioli R, et al. Among authors: franzosi mg. Circulation. 2002 Apr 23;105(16):1897-903. doi: 10.1161/01.cir.0000014682.14181.f2. Circulation. 2002. PMID: 11997274 Clinical Trial.
ISIS-4. GISSI-3 Investigators.
Tognoni G, Franzosi M, Latini R, Maggioni AP, Zuanetti G. Tognoni G, et al. Lancet. 1995 May 27;345(8961):1373-4; author reply 1374-5. Lancet. 1995. PMID: 7619151 No abstract available.
Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups.
Budaj A, Yusuf S, Mehta SR, Fox KA, Tognoni G, Zhao F, Chrolavicius S, Hunt D, Keltai M, Franzosi MG; Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators. Budaj A, et al. Among authors: franzosi mg. Circulation. 2002 Sep 24;106(13):1622-6. doi: 10.1161/01.cir.0000029926.71825.e2. Circulation. 2002. PMID: 12270853 Clinical Trial.
Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
Avanzini F, Ferrario G, Santoro L, Peci P, Giani P, Santoro E, Franzosi MG, Tognoni G; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico-3 Investigators. Avanzini F, et al. Among authors: franzosi mg. Am Heart J. 2002 Dec;144(6):1018-25. doi: 10.1067/mhj.2002.126739. Am Heart J. 2002. PMID: 12486426 Clinical Trial.
Ergometric score systems after myocardial infarction: prognostic performance of the Duke Treadmill Score, Veterans Administration Medical Center Score, and of a novel score system, GISSI-2 Index, in a cohort of survivors of acute myocardial infarction.
Villella M, Villella A, Santoro L, Santoro E, Franzosi MG, Maggioni AP; Duke Treadmill Score; Veterans Administration Medical Center Score; GISSI-2 Investigators. Villella M, et al. Among authors: franzosi mg. Am Heart J. 2003 Mar;145(3):475-83. doi: 10.1067/mhj.2003.162. Am Heart J. 2003. PMID: 12660671 Clinical Trial.
Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
Tavazzi L, Tognoni G, Franzosi MG, Latini R, Maggioni AP, Marchioli R, Nicolosi GL, Porcu M; GISSI-HF Investigators. Tavazzi L, et al. Among authors: franzosi mg. Eur J Heart Fail. 2004 Aug;6(5):635-41. doi: 10.1016/j.ejheart.2004.03.001. Eur J Heart Fail. 2004. PMID: 15302013 Free article. Clinical Trial.
193 results